BioAtla BCAB
NASDAQ BCAB
$1.40 +0.08 (+6.06%)
At close: Sep 8, 2026 · 4:00 PM EDT

BioAtla (BCAB) Price to Book (2020 - 2026)

BioAtla's (BCAB) quarterly Price to Book came in at 0.19 in Q2 2026, up 99.73% on a YoY basis from 0.1 in Q2 2025, and up 46.93% quarter-over-quarter from 0.36 in Q1 2026.

Analysis

BioAtla (BCAB) Price to Book (2020 - 2026) Analysis & Trends

BioAtla (BCAB) has reported Price to Book for 7 consecutive years, with 0.19 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Price to Book rose 99.73% year-over-year to 0.19; the trailing twelve-month figure through Jun 2026 stood at 0.19 (up 99.73% YoY), and the FY2025 full-year result was 49.78, down 141.35% from the prior year.
  • Price to Book improved to 0.19 in Q2 2026 per BCAB's latest filing, from 0.36 in the prior quarter.
  • Across five years, Price to Book topped out at 1851.33 in Q1 2025 and bottomed at 69.43 in Q2 2025.
  • Historically, Price to Book has averaged 152.89 across 5 years, with a median of 52.4 in 2022.
  • The widest YoY moves for Price to Book: up 1012.37% in 2025, down 165.8% in 2025.
  • Over 5 years, Price to Book stood at 105.99 in 2022, then dropped by 21.05% to 83.68 in 2023, then soared by 43.88% to 120.39 in 2024, then slumped by 141.35% to 49.78 in 2025, then soared by 99.62% to 0.19 in 2026.
  • According to Business Quant data, Price to Book over the past three periods registered 0.19, 0.36, and 49.78 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 BioAtla 2.33 Mn 2.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.19
Mar 31, 2026 -0.36
Dec 31, 2025 -49.78
Sep 30, 2025 -64.74
Jun 30, 2025 -69.43
Mar 31, 2025 1,851.33
Dec 31, 2024 120.39
Sep 30, 2024 185.23
Jun 30, 2024 105.53
Mar 31, 2024 166.43
Dec 31, 2023 83.68
Sep 30, 2023 43.00
Jun 30, 2023 57.59
Mar 31, 2023 40.81
Dec 31, 2022 105.99
Sep 30, 2022 98.16
Jun 30, 2022 31.09
Mar 31, 2022 47.21
Dec 31, 2021 166.67
Sep 30, 2021 224.58